Name | mestranol |
Synonyms | MESTRANOL mestranol (5beta)-stigmastane 17alpha-19-Norpregna-1,3,5(10)-trien-20-yn 17-ethynyl-3-methoxyestra-1,3,5(10)-trien-17-ol 19-nor-17α-pregna-1,3,5(10)-trien-20-yn-17-ol,3-methoxy- (17beta)-17-ethynyl-3-methoxyestra-1,3,5(10)-trien-17-ol 17a-Ethynyl-1,3,5(10)-estratriene-3,17b-diol 3-methyl ether 19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy- 19-Norpregna-1,3,5(10)-trien-20-yn-17-ol, 3-methoxy-, (17alpha)- 3,17-beta-dihydroxy-17-alpha-ethynyl-1,3,5(10)-estratriene-3-methylether 3,17-beta-Dihydroxy-17-alpha-ethynyl-1,3,5(10)-estratriene-3-methyl ether 17-eth-1-ynyl-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ol |
CAS | 72-33-3 |
EINECS | 200-777-8 |
InChI | InChI=1/C29H52/c1-7-22(20(2)3)12-11-21(4)25-15-16-26-24-14-13-23-10-8-9-18-28(23,5)27(24)17-19-29(25,26)6/h20-27H,7-19H2,1-6H3/t21-,22-,23+,24+,25-,26+,27+,28+,29-/m1/s1 |
Molecular Formula | C21H26O2 |
Molar Mass | 310.43 |
Density | 1.0865 (rough estimate) |
Melting Point | 153-155°C(lit.) |
Boling Point | 390.58°C (rough estimate) |
Specific Rotation(α) | +2~+8°(D/20℃)(c=1, 1,4-dioxane) |
Flash Point | 224.1°C |
Vapor Presure | 2.38E-08mmHg at 25°C |
Appearance | neat |
Merck | 5917 |
BRN | 2625905 |
pKa | 13.10±0.40(Predicted) |
Storage Condition | Sealed in dry,2-8°C |
Refractive Index | 1.4900 (estimate) |
MDL | MFCD00003689 |
In vitro study | Mestranol is extensively metabolized to hydroxylated products, and its biological activity is not well characterized. |
In vivo study | In rats, Mestranol (0.2 mg/kg) caused an increase in the percentage of AHF expressing glutathione-S-transferase (PGST) in the liver. Compared with the control group, Mestranol administration increased the hepatocyte labeling index of the lesion, with this trend at the lower dose and a significant difference at the higher dose. Mestranol (0.02 mg/kg and 0.2 mg/kg diet), resulted in a reduction in the non-focal labeling index compared to corresponding concentrations of Mestranol alone. Mestranol significantly increased the labeling index of non-lesional livers in uninitiated rats compared to rats fed only the basal diet. Mestranol (50 mg/100 mg B. wt.) the apparent number of α-2-adrenoceptors in the frontal cortex and the nucleus tractus solitarius (NTS) of rats was significantly reduced, while the apparent number of α-1 and α-2-adrenoceptors in the locus coeruleus was reduced. |
Hazard Symbols | Xn - Harmful |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R40 - Limited evidence of a carcinogenic effect R48 - Danger of serious damage to health by prolonged exposure R68 - Possible risk of irreversible effects |
Safety Description | S22 - Do not breathe dust. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) S36/37 - Wear suitable protective clothing and gloves. |
WGK Germany | 3 |
RTECS | RC8960000 |
HS Code | 29372900 |
Toxicity | LD50 oral in rat: > 10gm/kg |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.221 ml | 16.107 ml | 32.213 ml |
5 mM | 0.644 ml | 3.221 ml | 6.443 ml |
10 mM | 0.322 ml | 1.611 ml | 3.221 ml |
5 mM | 0.064 ml | 0.322 ml | 0.644 ml |